Separation methods for alkylating antineoplastic compounds. (Q34510200)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Separation methods for alkylating antineoplastic compounds (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A Paci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A Rieutord

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

F Brion

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

P Prognon

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

Journal of Chromatography B: Biomedical Sciences and Applications

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

255-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of busulfan in plasma by GC-MS with selected-ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Gas chromatographic determination of busulfan in plasma with electron-capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Measurement of busulfan in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Stability-indicating high-performance liquid chromatographic assay of busulfan in aqueous and plasma samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of busulfan in human plasma using high-performance liquid chromatography with pre-column derivatization and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Measurement of plasma busulfan concentration by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

A gas-chromatographic assay method for busulfan with sensitivity for test dose therapeutic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of busulfan in human plasma by gas chromatography with electron-capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantitation of busulfan in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantification of busulfan in plasma by gas chromatography-mass spectrometry following derivatization with tetrafluorothiophenol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Direct gas chromatographic determination of dechloroethylcyclophosphamide following microsomal incubation of cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic determination of busulfan in human serum with on-line derivatization, column switching and ultraviolet absorbance detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Gas-chromatographic analysis of busulfan for therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of busulfan in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic-mass spectrometric assay of busulfan in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Liquid chromatographic-mass spectrometric determination of the novel, recently identified thioTEPA metabolite, thioTEPA-mercapturate, in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Gas-liquid chromatographic analysis of N,N',N''-triethylene thiophosphoramide and N,N',N''-triethylene phosphoramide in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Dosing of thioTEPA for myeloablative therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatography of the anti-tumour agent triethylenethiophosphoramide and its metabolite triethylenephosphoramide with sodium sulphide, taurine and o-phthalaldehyde as pre-column fluorescent derivatization reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic analysis of N,N',N"-triethylenethiophosphoramide in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Stability of thiotepa (lyophilized) in 0.9% sodium chloride injection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Stability of thiotepa (lyophilized) in 5% dextrose injection at 4 and 23 degrees C

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of N,N′,N″-triethylenthiophosphoramide in biological samples using capillary gas chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Degradation study of thiotepa in aqueous solutions.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of altretamine in human plasma with high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

The long term stability of mechlorethamine hydrochloride (nitrogen mustard) ointment measured by HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Pharmacokinetics of chlorambucil in ovarian carcinoma using a new HPLC assay

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of chlorambucil in plasma by GLC with selected-ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Studies on the quantitation of chlorambucil in plasma by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic method for the separation of chlorambucil and its N-oxide prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatography of chlorambucil analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of chlorambucil in plasma using reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Kinetics of chlorambucil hydrolysis using high-pressure liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Degradation of chlorambucil in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Rapid assay for plasma chlorambucil and phenyl acetic mustard using reversed-phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Mass spectrometry of chlorambucil, its degradation products, and its metabolite in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

HPLC, MS, and pharmacokinetics of melphalan, bisantrene and 13-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic analysis of melphalan in plasma, brain and peripheral tissue by o-phthalaldehyde derivatization and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantitation of melphalan in plasma of patients by reversed-phase high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic assay for melphalan in human plasma. Application to pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Modified extraction and chromatography for the measurement of plasma melphalan by ion-pair high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Measurement of plasma melphalan at therapeutic concentrations using isocratic high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Direct injection analysis of melphalan in plasma using column-switching high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of reactive nitrogen mustard anticancer drugs in plasma by high-performance liquid chromatography using derivatization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantitative analysis of melphalan and its major hydrolysate in patients and animals by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-Pressure Liquid Chromatographic Analysis of Melphalan in Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of melphalan in the perfusate from patients treated by regional perfusion chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

A stability-indicating method for the determination of melphalan and related impurity content by gradient HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantitative determination of melphalan in plasma by liquid chromatography after derivatization with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Solvent-sample interactions in thermospray mass spectrometry of antineoplastic nitrogen mustards

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Chromatographic analysis of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Gas-Liquid Chromatographic Determination of Melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of estramustine and its 17-keto metabolite in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of estramustine phosphate and its metabolites estromustine, estramustine, estrone and estradiol in human plasma by liquid chromatography with fluorescence detection and gas chromatography with nitrogen-phosphorus and mass spectrometric

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Pharmacokinetics of ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Regulatory issues in the evaluation of antimetastatic and other novel anticancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Analytical and preparative high-performance liquid chromatographic separation of the enantiomers of ifosfamide, cyclophosphamide and trofosfamide and their determination in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of urinary 2- and 3-dechloroethylated metabolites of ifosfamide by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Gas chromatographic determination of 2- and 3-dechloroethylifosfamide in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic determination of stabilized 4-hydroxyifosfamide in human plasma and erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Measurement of 4-hydroxycyclophosphamide in serum by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of cyclophosphamide in urine by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of the enantiomers of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in plasma and urine using enantioselective gas chromatography with mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide and iphosphoramide mustard in plasma by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography-mass spectrometry and gas chromatography-nitrogen-phosphorus detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

A simple quantitative HPLC assay for ifosfamide in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic measurement of cyclophosphamide in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Enantiomeric separation of R- and S-ifosfamide and their determination in serum from clinical subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic determination of the enantiomers of cyclophosphamide in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Rapid method for the determination of ifosfamide and cyclophosphamide in plasma by high-performance liquid chromatography with solid-phase extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Analysis of ifosforamide mustard, the active metabolite of ifosfamide, in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Combined thin-layer chromatography—photography—densitometry for the quantitation of cyclophosphamide and its four principal urinary metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantification of 4-hydroxyifosfamide in plasma of ifosfamide-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of the underivatized antineoplastic drugs cyclophosphamide and 5-fluorouracil and some of their metabolites by capillary gas chromatography combined with electron-capture and nitrogen-phosphorus selective detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of cyclophosphamide in whole blood and plasma by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Liquid chromatographic determination of cyclophosphamide enantiomers in plasma by precolumn chiral derivatization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of 4-hydroxycyclophosphamide in plasma, as 2,4-dinitrophenylhydrazone derivative of aldophosphamide, by liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of acrolein in urine by liquid chromatography and fluorescence detection of its quinoline derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic method for quantitation of acrolein in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Quantitative high-performance liquid chromatographic determination of acrolein in plasma after derivatization with Luminarin® 3

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-Performance Liquid Chromatographic–Fluorescent Method to Determine Chloroacetaldehyde, a Neurotoxic Metabolite of the Anticancer Drug Ifosfamide, in Plasma and in Liver Microsomal Incubations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of tallimustine in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of tauromustine, a nitrosourea-based antitumour agent, in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of tauromustine and its demethylated metabolites in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Specific high-performance liquid chromatographic assay with ultraviolet detection for the determination of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Clinical pharmacokinetics of high-dose DTIC

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Simultaneous determination of dacarbazine, its photolytic degradation product, 2-azahypoxanthine, and the metabolite 5-aminoimidazole-4-carboxamide in plasma and urine by high-pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Compatibility of plastics with cytotoxic drug solutions-comparison of polyethylene with other container materials

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Colorimetric determination of dialkyltriazenoimidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Simple and sensitive method for the determination of cyclophosphamide by means of a nitrogen--phosphorus-selective detector

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of acrolein in human urine by headspace gas chromatography and mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

Reversed-phase high-performance liquid chromatography of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900280-8

7 January 2021

10.1016/S0378-4347(01)00280-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817031%20AND%20SRC:MED&resulttype=core&format=json